Jennifer Levin Carter's Insider Trades & SAST Disclosures
Jennifer Levin Carter's most recent trade in Oncocyte Corporation was a trade of 45,000 Option to Purchase Common Stock done . Disclosure was reported to the exchange on Aug. 15, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jennifer Levin Carter.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncocyte Corporation | Jennifer Levin Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 45,000 | 45,000 | - | - | Option to Purchase Common Stock | |
| Oncocyte Corporation | Jennifer Levin Carter | Director | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 15 Aug 2022 | 10,500 | 30,500 (0%) | 0% | 1.0 | 9,975 | Common Stock, no par value |
| Oncocyte Corporation | Jennifer Levin Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 10,000 | 20,000 (0%) | 0% | 0 | Common Stock, no par value | |
| Oncocyte Corporation | Jennifer Levin Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 10,000 | 0 | - | - | Restricted Stock Units | |
| Oncocyte Corporation | Jennifer Levin Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock, no par value | |
| CareMax Inc - Ordinary Sha... | Jennifer Levin Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 18,585 | 18,585 | - | - | Restricted Stock Units | |
| CareMax Inc - Ordinary Sha... | Jennifer Levin Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 15,500 | 15,500 | - | - | Restricted Stock Units | |
| Oncocyte Corporation | Jennifer Levin Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 45,000 | 45,000 | - | - | Option to Purchase Common Stock | |
| Oncocyte Corporation | Jennifer Levin Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 10,000 | 10,000 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges